Author:
Nord C E,Lindmark A,Person I
Abstract
The activity of FCE 22101 against 675 strains of anaerobic bacteria was determined by an agar dilution method. Its activity was compared with those of benzylpenicillin, piperacillin, cefoxitin, imipenem, clindamycin, metronidazole, chloramphenicol, vancomycin, fusidic acid, and bacitracin. FCE 22101 and imipenem (MIC, less than or equal to 0.5 mg/liter) were the most active agents against the anaerobic strains tested, except against Clostridium difficile strains. On the basis of these results, FCE 22101 appears to be a promising antimicrobial agent for treatment of anaerobic infections, and further clinical investigations are indicated.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference4 articles.
1. Antibiotic susceptibility of anaerobic bacteria with special reference to Bacteroides fragilis;Dornbusch K.;Scand. J. Infect. Dis.,1979
2. Holdeman L. V. E. P. Cato and W. E. C. Moore (ed.). 1977. Anaerobe laboratory manual 4th ed. Virginia Polytechnic Institute and State University Blacksburg.
3. The in vitro activity of a novel penem FCE 22101 compared to other betalactam antibiotics;Neu H. C.;J. Antimicrob. Chemother.,1985
4. Aspects on antimicrobial treatment of anaerobic infections;Nordbring F.;Scand. J. Infect. Dis.,1982
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献